奥美沙坦酯氨氯地平片
Olmesartan Medoxomil and Amlodipine Besylate Tablets
20 mg、5 mg
适用于治疗原发性高血压。本固定剂量复方适用于单用奥美沙坦酯或单用氨氯地平治疗血压控制效果不佳的成人患者
4类
（注：以上信息截止至2024年09月23日）
奥美沙坦酯氨氯地平片原研地产化说明书.
Lee Soo-Yun, Kim Jung-Ryul, Jung Jin Ah, et al. Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects[J]. Drug Des Devel Ther ,2015:9.
Rohatagi S , Lee J , Shenouda M , et al. Pharmacokinetics of Amlodipine and Olmesartan After Administration of Amlodipine Besylate and Olmesartan Medoxomil in Separate Dosage Forms and as a Fixed‐Dose Combination[J]. The Journal of Clinical Pharmacology, 2008, 48.
